Dow Down 0.92% Nasdaq Down 0.83%

Intercept Pharmaceuticals, Inc. (ICPT)

-NasdaqGS
224.51 Down 1.20(0.53%) 4:00PM EDT
|After Hours : 224.39 Down 0.12 (0.05%) 7:22PM EDT
Prev Close:225.71
Open:228.03
Bid:224.40 x 100
Ask:230.87 x 100
1y Target Est:473.43
Beta:-4.55
Earnings Date:Nov 12 - Nov 17 (Est.)
Day's Range:219.02 - 228.03
52wk Range:46.81 - 497.00
Volume:311,154
Avg Vol (3m):478,945
Market Cap:4.76B
P/E (ttm):N/A
EPS (ttm):-12.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ICPTDown 0.53%4.76B
AZNDown 0.32%86.87B
SLXPDown 2.09%8.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,882.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-13.15
Quarterly EPS Est (Sep-14) :-1.10
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):4.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback